Ohr Pharmaceutical Announces $5 Million Financing from Exercise of Warrants

Additionally, as an incentive to encourage exercise of the Series B Warrants, the Company offered to those Series B Warrant holders that exercise at least 33% of their Series B Warrants, an extension of their remaining Series B Warrants until September …
See all stories on this topic »